NICE recommends ticagrelor with aspirin for three years post-MIBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4438 (Published 12 August 2016) Cite this as: BMJ 2016;354:i4438
- Jacqui Wise
Patients who have had a myocardial infarction (MI) should be given a low dose of the anti-clotting drug ticagrelor (Brilique) together with aspirin for as long as three years, new draft guidance from the National Institute for Health and Care Excellence (NICE) says.1
Most centres in the United Kingdom already use a higher (90 mg) dose of ticagrelor in combination with aspirin for as long as 12 months as first line management …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial